INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969 | -30.7% | 38,387 | -53.2% | 0.08% | -39.9% |
| Q1 2023 | $1,399 | +12.6% | 82,072 | +32.0% | 0.14% | -10.4% |
| Q4 2022 | $1,242 | -99.9% | 62,184 | -27.3% | 0.15% | -36.9% |
| Q3 2022 | $1,842,000 | +544.1% | 85,531 | +603.8% | 0.24% | +542.1% |
| Q1 2022 | $286,000 | -58.4% | 12,152 | -39.8% | 0.04% | -66.7% |
| Q1 2021 | $687,000 | +56.1% | 20,182 | +52.6% | 0.11% | +58.3% |
| Q4 2020 | $440,000 | -84.6% | 13,224 | -85.1% | 0.07% | -84.9% |
| Q3 2020 | $2,861,000 | +626.1% | 89,029 | +299.1% | 0.48% | +800.0% |
| Q3 2019 | $394,000 | -37.0% | 22,310 | +3.7% | 0.05% | -15.9% |
| Q1 2019 | $625,000 | +1.1% | 21,513 | +8.5% | 0.06% | +65.8% |
| Q4 2017 | $618,000 | +17.9% | 19,824 | +18.0% | 0.04% | +5.6% |
| Q3 2017 | $524,000 | +39.4% | 16,794 | -19.0% | 0.04% | +100.0% |
| Q4 2015 | $376,000 | -54.9% | 20,742 | -53.8% | 0.02% | -56.1% |
| Q3 2015 | $834,000 | – | 44,893 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |